Amicus Therapeutics competitors

Amicus Therapeutics's competitors include Mast Therapeutics, Zogenix, Clinigen Group and BTG
Add company...
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Mast Therapeutics
A San Diego-based biopharmaceutical company.
Zogenix
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
BTG
BTG is an international specialist healthcare company.
Founding Date
Founding Date
2002
Founding Date
1995
Founding Date
2006
Founding Date
2010
Founding Date
1948
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cranbury Township, US HQ
Puteaux, FR
Munich, DE
Amsterdam, NL
Denham, GB
Locations
San Diego, US HQ
Locations
Emeryville, US HQ
Maidenhead, GB
San Diego, US
Locations
Burton upon Trent, GB HQ
Locations
London, GB HQ
Rosedale, AU
Ottawa, CA
Alzenau, DE
Hong Kong, HK
Neihu District, TW
Brentwood, US
see more
Employees
Employees
263
Employees
14133% increase
Employees
67
Employees
465200% increase
Employees
1,355
Valuation ($)
Valuation ($)
3.1 b
Valuation ($)
403.5 m
Valuation ($)
1.6 b
Valuation ($)
1.8 b
Valuation ($)
3.9 b
Twitter followers
Twitter followers
793
Twitter followers
873
Twitter followers
475
Twitter followers
1.2 k
Twitter followers
786

Financial

Revenue (est.)
Revenue (est.)
$36.9m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$9.8m (FY, 2017)
Revenue (est.)
£302.3m (FY, 2017)
Revenue (est.)
£570.5m (FY, 2017)
Cost of goods
Cost of goods
$6.2m (FY, 2017)
Cost of goods
N/A
Cost of goods
$10.7m (FY, 2017)
Cost of goods
£179.6m (FY, 2017)
Cost of goods
£179.9m (FY, 2017)
Gross profit
Gross profit
$30.7m (FY, 2017)
Gross profit
N/A
Gross profit
($908k) (FY, 2017)
Gross profit
£122.7m (FY, 2017)
Gross profit
£390.6m (FY, 2017)
Net income
Net income
N/A
Net income
($29.8m) (FY, 2017)
Net income
($126.8m) (FY, 2017)
Net income
£3.8m (FY, 2017)
Net income
£33.6m (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Mast Therapeutics
HQ
San Diego, US
Employees
14

A San Diego-based biopharmaceutical company.

View company
Zogenix
HQ
Emeryville, US
Employees
67

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.

View company
Clinigen Group
HQ
Burton upon Trent, GB
Employees
465

A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time

View company
BTG
HQ
London, GB
Employees
1,355

BTG is an international specialist healthcare company.

View company